Skip to content
Search

Latest Stories

Levothyroxine 12.5mcg tablets face supply disruption

Pb Staff writer
By Pb Staff writerFeb 05, 2021
Pb Staff writer
See Full Bio

The Department of Health and Social Care (DH) has issued a serious shortage protocol (SSP) for Levothyroxine 12.5mcg tablets following severe supply disruption.

Effective from Wednesday (Feb 3), SSP10 has provided pharmacists a suitable alternative product- one Levothyroxine 25mcg tablet in response to the serious shortage affecting the supply of 12.5mcg tablets.

For prescriptions (NHS or private) requesting:Supply permitted under SSP10:
Levothyroxine 12.5mcg tablets (56 tablets)Levothyroxine25mcg tablets (28 tablets)

The SSP is currently scheduled to expire on March 5.

The reimbursement price will account for VAT payment. Supply in accordance with the SSP will result in the following fees being paid to the contractor…

  • One Single Activity fee (currently £1.27)
  • One SSP fee (£5.35)

Related News

Community pharmacy has a “vital role to play in rebuilding our NHS” Starmer tells Sigma Conference
News

Community pharmacy has a “vital role to play in rebuilding our NHS” Starmer tells Sigma Conference

Pharmacies warn against buying unlicensed hay fever treatment Kenalog® online
News

Don’t buy unlicensed hay fever drug Kenalog® online, pharmacies warn

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing
News

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

New professional liability insurance policy for RPS members launched
News

RPS launches professional liability insurance for members

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc